Related references
Note: Only part of the references are listed.Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine Tumors
Gitte Dam et al.
NEUROENDOCRINOLOGY (2020)
Overexpression of MicroRNA miR-7-5p Is a Potential Biomarker in Neuroendocrine Neoplasms of the Small Intestine
Anna E. Heverhagen et al.
NEUROENDOCRINOLOGY (2018)
DcR3, TFF3, and Midkine Are Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors
Katarina Edfeldt et al.
NEUROENDOCRINOLOGY (2017)
NET Blood Transcript Analysis Defines the Crossing of the Clinical Rubicon: When Stable Disease Becomes Progressive
Marianne Pavel et al.
NEUROENDOCRINOLOGY (2017)
Serum protein fingerprinting by PEA immunoassay coupled with a pattern-recognition algorithms distinguishes MGUS and multiple myeloma
Petra Schneiderova et al.
ONCOTARGET (2017)
Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma
Michaela Bowden et al.
ONCOTARGET (2017)
A multiplex platform for the identification of ovarian cancer biomarkers
Kristin L. M. Boylan et al.
CLINICAL PROTEOMICS (2017)
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Arvind Dasari et al.
JAMA ONCOLOGY (2017)
Prospective evaluation and treatment of familial carcinoid small intestine neuroendocrine tumors (SI-NETs)
Marybeth S. Hughes et al.
SURGERY (2016)
A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management
Kjell Oberg et al.
ENDOCRINE CONNECTIONS (2016)
The Clinical Utility of a Novel Blood-Based Multi-Transcriptome Assay for the Diagnosis of Neuroendocrine Tumors of the Gastrointestinal Tract
I. M. Modlin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Consensus on biomarkers for neuroendocrine tumour disease
Kjell Oberg et al.
LANCET ONCOLOGY (2015)
A novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes' stages A-D colorectal cancers
Sadia Mahboob et al.
CLINICAL PROTEOMICS (2015)
Exploring the Rising Incidence of Neuroendocrine Tumors: A Population-Based Analysis of Epidemiology, Metastatic Presentation, and Outcomes
Julie Hallet et al.
CANCER (2015)
Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
Eva Tiensuu Janson et al.
ACTA ONCOLOGICA (2014)
Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature
M. Fraenkel et al.
ENDOCRINE-RELATED CANCER (2014)
A multianalyte PCR blood test outperforms single analyte ELISAs (chromogranin A, pancreastatin, neurokinin A) for neuroendocrine tumor detection
Irvin M. Modlin et al.
ENDOCRINE-RELATED CANCER (2014)
Clinical Application of MicroRNA Testing in Neuroendocrine Tumors of the Gastrointestinal Tract
Caterina Vicentini et al.
MOLECULES (2014)
Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability
Erika Assarsson et al.
PLOS ONE (2014)
Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors
Su-Chen Li et al.
MODERN PATHOLOGY (2013)
The Identification of Gut Neuroendocrine Tumor Disease by Multiple Synchronous Transcript Analysis in Blood
Irvin M. Modlin et al.
PLOS ONE (2013)
Chromogranin A is a sensitive marker of progression or regression in ileo-cecal neuroendocrine tumors
Kenneth Hojsgaard Jensen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)
Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs)
George Kanakis et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2012)
Limitations of Chromogranin A in clinical practice
Vincenzo Marotta et al.
BIOMARKERS (2012)
A Prospective Evaluation of the Effect of Chronic Proton Pump Inhibitor Use on Plasma Biomarker Levels in Humans
Daniel Raines et al.
PANCREAS (2012)
The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors
Ben Lawrence et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2011)
Elevated Plasma Chromogranin A Is the First Indication of Recurrence in Radically Operated Midgut Carcinoid Tumors
Staffan Welin et al.
NEUROENDOCRINOLOGY (2009)
A comprehensive comparison of random forests and support vector machines for microarray-based cancer classification
Alexander Statnikov et al.
BMC BIOINFORMATICS (2008)
One hundred years after Carcinoid: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study
Maria Chiara Zatelli et al.
ENDOCRINE-RELATED CANCER (2007)
Automated diagnosis of brain tumours astrocytomas using Probabilistic Neural Network clustering and Support Vector Machines
D Glotsos et al.
INTERNATIONAL JOURNAL OF NEURAL SYSTEMS (2005)
Support vector machine classification and validation of cancer tissue samples using microarray expression data
TS Furey et al.
BIOINFORMATICS (2000)
Share Paper
